Lilly drug slows Alzheimer's progression by 35% in trial

preview_player
Показать описание
An experimental Alzheimer's drug developed by Eli Lilly slowed cognitive decline by 35% in a closely watched late-stage trial, the company said, raising hopes for another treatment for the brain disorder that slowly destroys memory.

#Alzheimers #donanemab #EliLilly #News #Reuters #newsfeed

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Рекомендации по теме